Reply to: "Appropriate use of cholesterol-lowering therapy"

被引：0
|
作者：
Langsted, Anne [1 ,2 ]
Freiberg, Jacob J. [3 ,4 ]
Nordestgaard, Borge G. [1 ,2 ]
机构：
[1] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Biochem, Herlev & Gentofte Hosp,Copenhagen Univ Hosp, Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Gen Populat Study, Herlev & Gentofte Hosp,Copenhagen Univ Hosp, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark
[4] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Herlev, Denmark
来源：
ATHEROSCLEROSIS | 2017年 / 262卷
关键词：
Statins; Cholesterol; Cardiovascular disease; Prevention; Lipoproteins;
D O I：
10.1016/j.atherosclerosis.2017.03.017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：200 / 201
页数：2
相关论文
共 50 条
  • [1] Appropriate use of cholesterol-lowering therapy
    Falk, Erling
    ATHEROSCLEROSIS, 2017, 262 : 198 - 199
  • [2] Cholesterol-lowering therapy - Response
    Matsuoka, H
    Tamai, O
    Imaizumi, T
    CIRCULATION, 1997, 96 (10) : 3801 - 3802
  • [3] Cholesterol-lowering therapy for smokers
    Jackson, PR
    LANCET, 2001, 357 (9260): : 960 - 960
  • [4] Pharmacogenomics of cholesterol-lowering therapy
    Schmitz, G
    Langmann, T
    VASCULAR PHARMACOLOGY, 2006, 44 (02) : 75 - 89
  • [5] Use of skin cholesterol to monitor response to cholesterol-lowering therapy.
    Evelegh, MJ
    Norton, HBB
    Sprecher, DL
    CLINICAL CHEMISTRY, 1999, 45 (06) : A29 - A29
  • [6] Need to individualise cholesterol-lowering therapy
    Luetjohann, Dieter
    Weingaertner, Oliver
    HEART, 2019, 105 (16)
  • [7] The future direction of cholesterol-lowering therapy
    Evans, M
    Roberts, A
    Rees, A
    CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (06) : 663 - 669
  • [8] Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy
    Schmitz, Gerd
    Schmitz-Madry, Anna
    Ugocsai, Peter
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (02) : 164 - 173
  • [9] Cholesterol-lowering therapy: Is there really a controversy?
    Jungnickel, PW
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (05) : 539 - 542
  • [10] Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy
    Schmitz, G
    Drobnik, W
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (04) : 581 - 589
12345